Search Results 251-260 of 8463 for TNF

1. A Study to Evaluate the Safety, Tolerability, and Activity of Escalating Doses of AK002 in Patients with Eosinophilic Gastritis (EG) and/or Eosinophilic Gastroenteritis (EGE) - Mayo Clinic

   ... TNF, anti-IL-5, anti-IL-5 receptor, dupilumab, anti-IgE antibodies, omalizumab) or systemic corticosteroids with a daily dose >10 mg of prednisone or ...

2. Publications - Stanimir Vuk-Pavlovic, Ph.D. - Mayo Clinic

   ... tumor necrosis factor-alpha in human epithelial tumor cells. J Cell Biochem. 1992 Feb; 48 (2):203-14. View PubMed; Marusic M, Bajzer Z, Freyer JP, Vuk ...

3. Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates (COLT) - Mayo Clinic

   ... TNF-alpha inhibitors) and/or combination immunosuppressive drugs for any autoimmune or other conditions in the last 3 months, except corticosteroids as below

4. Orhun H. Kantarci, M.D. - Mayo Clinic Faculty Profiles

   " They also have published the first open-label trial of using TNF-alpha inhibitors to successfully arrest Neuro-Behcet syndrome when other strategies fail for ...

5. A 2-Part Phase 2 Study to Evaluate the Efficacy and Safety of GS-1427 in Adult Participants With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   ... TNF-? inhibitors, counts as 1 mechanism of action) Key Exclusion Criteria: * Have a current diagnosis of Crohn's Disease (CD) or clinical findings ...

6. Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa - Mayo Clinic

   Received any anti-TNF-α/other biologics treatment within 12 weeks or 5 elimination half‑lives, whichever is longer, before the Baseline Visit. Received ...

7. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

   ... tumor necrosis factor [anti-TNF] agents) within 2 weeks prior to randomization. Patients who have received acute, low-dose (≤ 10 mg oral prednisone or ...

8. ICD-11 World Health Organization.

9. A Study to Evaluate the Effectiveness and Safety of Oral OPS-2071 in Subjects With Crohn's Disease Showing Symptoms of Active Inflammation - Mayo Clinic

   ... tumor necrosis factor-alpha [TNF-α] monoclonal antibody), immunosuppressants, low-dose steroids, or 5-aminosalicylic acid (5-ASA) formulations. Subjects who ...

10. Publications - Abinash Virk, M.D. - Mayo Clinic

    Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination. ... Tumor Necrosis Factor-Alpha ...